Recursion's Chris Gibson on the potential utility of machine learning and AI in drug development

blonca9
Jan 11, 2024
1 min read

Chris Gibson describes the new technologies that are accelerating and refining drug development, shares best practices, and elaborates on Recursion's partnerships.

Recent Posts

See All

RBC Global Healthcare Conference: Korro Bio entered the clinic with its RNA editing platform in January and will have multiple cohorts of data in AATD later this year

RBC Global Healthcare Conference: With a phase 3 for its lead program scheduled to read in Q3 and mid-stage data for another program coming up this quarter, aTyr Pharma has pivotal months ahead

RBC Global Healthcare Conference: Ocular Therapeutix's Chairman & CEO Pravin Dugel provides an update on the progress of the pivotal studies for AXPAXLI in wet AMD

Recursion's Chris Gibson on the potential utility of machine learning and AI in drug development

Recent Posts

Join the BiotechTV mailing list

Follow BiotechTV

Sponsors

Sponsor Spotlight